Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01711.x/fullpdf
Reference83 articles.
1. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics;McPherson;BMJ,2000
2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A bibliometric and visualization analysis of research trends and hotspots on targeted therapy for breast cancer from 2003 to 2022;Frontiers in Oncology;2024-06-04
2. SLC35A2 expression is associated with HER2 expression in breast cancer;Discover Oncology;2024-04-19
3. What influences the activity of Degrader−Antibody conjugates (DACs);European Journal of Medicinal Chemistry;2024-03
4. Progress of PD-1/PD-L1 inhibitor combination therapy in immune treatment for HER2-positive tumors;European Journal of Clinical Pharmacology;2024-02-11
5. Human epidermal growth receptor polymorphisms (HER1–rs11543848 and HER2–rs1136201) exhibited significant association with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan;Health Science Reports;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3